Disease modification outcomes in type 2 diabetes: a modified Delphi
Study context
- Population
- Health-care professionals, researchers and patients; steering group of clinicians, researchers and people living with T2Dround one n=233
- Outcome
- Core outcome set for disease modification in T2D
Methodological detailsconducted according to COMET guidance, two Delphi rounds, international multidisciplinary steering group, Candidate outcomes identified from the literature and refined by the steering group
- Conducted according to COMET guidance
- Two Delphi rounds
- International multidisciplinary steering group
- Candidate outcomes identified from the literature and refined by the steering group
Recommendations
As reported in the abstract
Outcomes reaching agreement
35
Domains spanned
11
Original publication
Disease modification outcomes in type 2 diabetes: a modified Delphi. Lancet Diabetes Endocrinol. Published 29 September 2026. doi:10. 1016/ s2213-8587(26)00243-3
Composed by AI from the published abstract and checked against it. How Briefs are made →